Clinical Trial Update: Study to Evaluate Safety and Immunogenicity of nOPV2 at Different Intervals in Infants [Phase 3]

View source ↗

Summary

Results from a Phase 3 trial assessing safety and immunogenicity of nOPV2 at different intervals in infants have been completed and posted (2024-08-23).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• nOPV2 (novel oral polio vaccine type 2)

Snippet

Sponsor: Fidec Corporation | Conditions: Poliomyelitis | Phase 3 | Status: COMPLETED | Results posted: 2024-08-23